Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,225.00
-260.00 (-5.80%)
Oct 11, 2024, 3:30 PM KST
11.77%
Market Cap 115.42B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 69.11
Forward PE n/a
Dividend 35.00 (0.83%)
Ex-Dividend Date n/a
Volume 384,248
Open 4,440.00
Previous Close 4,485.00
Day's Range 4,215.00 - 4,460.00
52-Week Range 3,410.00 - 6,620.00
Beta 0.54
Analysts n/a
Price Target n/a
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.